AtriCure (ATRC) Tops Q3 EPS by 10c

AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.23), $0.10 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $70.5 million versus the consensus estimate of $68.68 million.

GUIDANCE:

AtriCure sees FY2021 EPS of ($1.20), versus the consensus of ($1.35). AtriCure sees FY2021 revenue of $270-275 million, versus the consensus of $272 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance